
eClinicalMedicine – The Lancet Discovery Science
@eClinicalMed
Followers
8K
Following
2K
Media
2K
Statuses
7K
Gold open access clinical journal, part of @TheLancet Discovery Science, influencing clinical practice and strengthening health. IF: 10·0; CiteScore: 17·0.
London UK - Boston USA
Joined May 2018
📢July issue now online featuring #BreastCancer, #RSV, #COVID19, #CrohnsDisease, #antimicrobial use, #osteoporosis, and much more with our editorial on whole-genome sequencing for newborns. …all available #OpenAccess❗️. Read more here: Attribution: Getty
1
0
3
Effects of therapeutic interventions on long COVID: a meta-analysis of randomized controlled trials. Advocates for updated clinical guidelines integrating multimodal therapies and underscores the urgency of large-scale trials to optimise dosing. #LongCOVID
0
2
1
Disease accumulation and distribution across lifespan in Swedish centenarians and non-centenarians: a nationwide study. Suggests preserved homeostatic capacity and sustained functional integrity despite cumulative physiological stressors in #centenarians.
0
0
2
RT @aipulserx: How can machine learning models predict which lung cancer surgery patients will develop life-threatening postoperative pulmo….
0
1
0
RT @Thoracic_PubMed: .@eClinicalMed.📚 Systematic Review & Meta-Analysis of 11 RCTs (Phase II/III) .👥 3,228 patients (67% male) with advanc….
0
1
0
Factors influencing prevalence and death rate of #COPD: a study of 201 countries and regions from 1990 to 2021. Various factors (tobacco, atmospheric pollution, biomass cooking, temperature, social factors, and comorbidities) significantly influence COPD.
0
0
0
RT @LSchwingshackl: Association between substituting macronutrients and all-cause mortality: a network meta-analysis of prospective obser….
thelancet.com
Our results provide practical knowledge for public health professionals and can inform upcoming dietary guidelines. The beneficial association of increasing PUFA (both n-3 and n-6) and (plant-) MUFA...
0
3
0
RT @BreastOncPubMed: .@eClinicalMed.Multicenter phase 2 trial NJMU-BC01 (n=74). De-escalated neoadjuvant nab-paclitaxel + pyrotinib + trast….
pubmed.ncbi.nlm.nih.gov
National Natural Science Foundation of China and Natural Science Foundation of Jiangsu Province.
0
1
0
RT @greg_folkers: .@eClinicalMed : Safety, tolerability and clinical effects of rovunaptabin, also known as BC007 on fatigue and quality o….
0
1
0
RT @TheLancet: 📢 Launch of The Lancet Countdown on Health and Plastics. On August 4, a new report will offer an up-to-date assessment of th….
tessforum.org
0
10
0
RT @TheLancetOncol: 📢Our Aug issue is now live: 📊Original research #prostatecancer, contraceptive use and #liverca….
0
4
0
Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: a phase 2 study. Obinutuzumab is active as single-agent induction and maintenance in patients with r/r Waldenström #macroglobulinaemia with manageable toxicity.
0
0
0
RT @cancer_K2A: 🚨 New RCT 📰 in @eClinicalMed.Online #Mindfulness intervention ⬇️'s fear of cancer recurrence (#FCR), anxiety & depression.A….
0
7
0
RT @mangelini_med: ❓What outcomes matter most in genital gender-affirming surgery (gGAS) research? . For years, studies on gGAS have report….
0
1
0
RT @ouedraogo_adama: We are delighted to share with you our new study on intimate partner violence during pregnancy (IPV-DP) in 57 countrie….
thelancet.com
Despite the implementation of numerous development programs aimed at reducing violence against women in LMICs in recent decades, IPVDP remains high in some countries and has even increased in others....
0
1
0
Risk of clinical events in virologically suppressed people with #HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation. Suggests that virologically suppressed PWH can be safely switched to a two-drug regimen.
0
0
0
RT @LancetGastroHep: Ahead of #WorldHepatitisDay on July 28th, we've published a collection of viral hepatitis-related content. Follow….
0
4
0
RT @LjiljanaMarina: Happy to have had the chance to collaborate with @IrinaBancos and David on this important project! 🙌.Tailoring mentorsh….
0
4
0
RT @lymphomahub: 📝Phase II Epi-RCHOP findings published in @eClinicalMed found that tazemetostat + R-CHOP achieved an estimated PFS and OS….
0
2
0